A new survey suggests that advocates have an opportunity to engage millennials in working toward unfettered access to reproductive health information and services.
A new Arkansas bill mentions abstinence explicitly while avoiding any direct mention of contraception—suggesting that state lawmakers are kidding themselves about the behavior of college students.
Two new reports show that hundreds of thousands of Texans lost access to family planning care in the wake of anti-choice lawmakers’ crusade against Planned Parenthood in 2011.
Legislators in Arizona are proposing a bill that would require doctors to tell abortion patients that the procedure can be “reversed”—the latest in a series of anti-choice efforts to put official government support behind the harassment of women.
It’s been two years since the FDA made certain types of emergency contraception available without a prescription to women of all ages, but Indian Health Service has yet to update its policy.
An Arkansas lawmaker has introduced a bill that would create a “contraception incentive” for low-income women in the state’s Medicaid program, intending to offer a “breather to think about their life decisions that are affecting us as taxpayers.”
A cluster of cases on the West Coast in which syphilis has infected patients’ eyes, and in some instances caused blindness, should serve to remind us that even curable STDs can cause serious complications.
Liletta, an IUD just approved by the FDA, is being marketed in the United States through a unique partnership between manufacturers who hope to bring the device to more people at a lower cost. However, it is still unclear whether those savings will be felt by all women.
Twitter has updated its rules that blocked many advertisements for condoms and sexual health. And condom retailer Lucky Bloke, the first company to speak out about the issue, finally had its advertising ban lifted after nine months of complaints and public campaigns to get the policy changed.
One in four people living with HIV in the United States are women. So why is HIV prevention medication overwhelmingly only targeted at men who have sex with men?